James McArthur
17Patents
8h-index
23Co-inventors
72Inventor score
Filing activity: May 28, 1999 → Feb 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6498244B1 | Adeno-associated virus capsid immunologic determinants | Chemistry; Metallurgy | 53 | Expired |
| US6733757B2 | Adeno-associated virus capsid immunologic determinants | Chemistry; Metallurgy | 46 | Expired |
| US7179903B2 | Liver specific transcriptional enhancer | Chemistry; Metallurgy | 41 | Expired |
| US7217421B1 | Cancer-associated antigens and methods of their identification and use | Human Necessities | 18 | Expired |
| US6808905B2 | Lentiviral vectors encoding clotting factors for gene therapy | Chemistry; Metallurgy | 17 | Expired |
| US6521602B1 | Anti-neoplastic compositions and uses thereof | Chemistry; Metallurgy | 13 | Expired |
| US7745179B2 | Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same | Chemistry; Metallurgy | 10 | Active |
| US6420345B1 | Methods and reagents for inhibiting angiogenesis | Chemistry; Metallurgy | 8 | Expired |
| US8591888B2 | Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders | Chemistry; Metallurgy | 4 | Active |
| US7972846B2 | Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders | Chemistry; Metallurgy | 4 | Active |
| US6413943B1 | Methods and reagents for inhibiting proliferation of smooth muscle cells | Chemistry; Metallurgy | 2 | Expired |
| US7226606B2 | Cancer-associated antigens and methods of their identification and use | Physics | 1 | Expired |
| US8940300B2 | Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods | Chemistry; Metallurgy | 1 | Active |
| US10792339B2 | Methods and compositions for treating phenylketonuria | Chemistry; Metallurgy | 0 | Active |
| US9315568B2 | Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders | Chemistry; Metallurgy | 0 | Active |
| US7645587B2 | Cancer-associated antigens and methods of their identification and use | Physics | 0 | Active |
| US12213975B2 | PDE9 inhibitors for treating sickle cell disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.